NCT06638931 2026-04-15ANTARESInstituto do Cancer do Estado de São PauloPhase 2 Recruiting28 enrolled
NCT06683846 2025-08-24Ivonescimab in the Treatment of Multiple Advanced TumorsFudan UniversityPhase 2 Recruiting400 enrolled